Hollander E - Search Results

1

Extended-release fluvoxamine and improvements in quality of life in patients with obsessive-compulsive disorder.

Koran LM, Bromberg D, Hornfeldt CS, Shepski JC, Wang S, Hollander E. Koran LM, et al. Among authors: hollander e. Compr Psychiatry. 2010 Jul-Aug;51(4):373-9. doi: 10.1016/j.comppsych.2009.10.001. Epub 2009 Dec 21. Compr Psychiatry. 2010. PMID: 20579510 Clinical Trial.

2

Venlafaxine in treatment-resistant obsessive-compulsive disorder.

Hollander E, Friedberg J, Wasserman S, Allen A, Birnbaum M, Koran LM. Hollander E, et al. J Clin Psychiatry. 2003 May;64(5):546-50. doi: 10.4088/jcp.v64n0508. J Clin Psychiatry. 2003. PMID: 12755657 Clinical Trial.

3

A double-blind, placebo-controlled study of the efficacy and safety of controlled-release fluvoxamine in patients with obsessive-compulsive disorder.

Hollander E, Koran LM, Goodman WK, Greist JH, Ninan PT, Yang H, Li D, Barbato LM. Hollander E, et al. J Clin Psychiatry. 2003 Jun;64(6):640-7. doi: 10.4088/jcp.v64n0604. J Clin Psychiatry. 2003. PMID: 12823077 Clinical Trial.

4

Double-blind, placebo-controlled trial of topiramate augmentation in treatment-resistant obsessive-compulsive disorder.

Berlin HA, Koran LM, Jenike MA, Shapira NA, Chaplin W, Pallanti S, Hollander E. Berlin HA, et al. Among authors: hollander e. J Clin Psychiatry. 2011 May;72(5):716-21. doi: 10.4088/JCP.09m05266gre. Epub 2010 Aug 10. J Clin Psychiatry. 2011. PMID: 20816027 Clinical Trial.

5

Fluvoxamine versus clomipramine for obsessive-compulsive disorder: a double-blind comparison.

Koran LM, McElroy SL, Davidson JR, Rasmussen SA, Hollander E, Jenike MA. Koran LM, et al. Among authors: hollander e. J Clin Psychopharmacol. 1996 Apr;16(2):121-9. doi: 10.1097/00004714-199604000-00004. J Clin Psychopharmacol. 1996. PMID: 8690827 Clinical Trial.

6

Serotonin-1D hypothesis of obsessive-compulsive disorder: an update.

Zohar J, Kennedy JL, Hollander E, Koran LM. Zohar J, et al. Among authors: hollander e. J Clin Psychiatry. 2004;65 Suppl 14:18-21. J Clin Psychiatry. 2004. PMID: 15554784 Review.

7

Neurological soft signs as predictors of treatment response to selective serotonin reuptake inhibitors in obsessive-compulsive disorder.

Hollander E, Kaplan A, Schmeidler J, Yang H, Li D, Koran LM, Barbato LM. Hollander E, et al. J Neuropsychiatry Clin Neurosci. 2005 Fall;17(4):472-7. doi: 10.1176/jnp.17.4.472. J Neuropsychiatry Clin Neurosci. 2005. PMID: 16387985 Clinical Trial.

8

Practice guideline for the treatment of patients with obsessive-compulsive disorder.

Koran LM, Hanna GL, Hollander E, Nestadt G, Simpson HB; American Psychiatric Association. Koran LM, et al. Among authors: hollander e. Am J Psychiatry. 2007 Jul;164(7 Suppl):5-53. Am J Psychiatry. 2007. PMID: 17849776 Review. No abstract available.

9

Adequacy of pharmacotherapy among medicaid-enrolled patients newly diagnosed with obsessive-compulsive disorder.

Hankin CS, Koran LM, Bronstone A, Black DW, Sheehan DV, Hollander E, Dunn JD, Culpepper L, Knispel J, Dougherty DD, Wang Z. Hankin CS, et al. Among authors: hollander e. CNS Spectr. 2009 Dec;14(12):695-703. doi: 10.1017/s1092852900023956. CNS Spectr. 2009. PMID: 20394177

10

A double-blind, placebo-controlled trial of topiramate for pathological gambling.

Berlin HA, Braun A, Simeon D, Koran LM, Potenza MN, McElroy SL, Fong T, Pallanti S, Hollander E. Berlin HA, et al. Among authors: hollander e. World J Biol Psychiatry. 2013 Mar;14(2):121-8. doi: 10.3109/15622975.2011.560964. Epub 2011 Apr 12. World J Biol Psychiatry. 2013. PMID: 21486110 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

574 results

Search Page

Filters